Preclinical study and phase I clinical safety evaluation of recombinant Mycobacterium tuberculosis ESAT6 protein

Medical science monitor basic research

Volumn 19, Issue , 2013, Pages 146-152

  Du, Wei Xin ^a   Chen, Bao Wen ^a   Lu, Jin Biao ^a   Gao, Meng Qiu ^a   Shen, Xiao Bing ^a   Yang, Lei ^a   Su, Cheng ^a   Wang, Guo Zhi ^a   Sun, Qing feng ^a   Xu, Miao ^a  

^a NATIONAL INSTITUTES FOR FOOD AND DRUG CONTROL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL PROTEIN; ESAT-6 PROTEIN, MYCOBACTERIUM TUBERCULOSIS; RECOMBINANT PROTEIN; TUBERCULIN;

ADULT; AGED; ANIMAL; CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG SCREENING; FEMALE; GUINEA PIG; HUMAN; IMMUNIZATION; IMMUNOLOGY; MALE; MIDDLE AGED; PHASE 1 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; TUBERCULIN TEST; YOUNG ADULT;

ADULT; AGED; ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; DRUG EVALUATION, PRECLINICAL; FEMALE; GUINEA PIGS; HUMANS; IMMUNIZATION; MALE; MIDDLE AGED; RECOMBINANT PROTEINS; TUBERCULIN; TUBERCULIN TEST; YOUNG ADULT;

EID: 84887459016     PISSN: None     EISSN: 23254416     Source Type: Journal    
DOI: 10.12659/MSMBR.883912     Document Type: Article

References (0)